Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 2Neoplasms 2Colonic Diseases 2Agnosia 2Visceral Pain 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

trimebutine 3-thiocarbamoylbenzenesulfonate 1Transcranial Magnetic Stimulation 1Saline Solution 1Butorphanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Visceral Pain × trimebutine 3-thiocarbamoylbenzenesulfonate × Clear all
NCT02276768 2016-08-10

Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method

gicare Pharma Inc.

Phase 1 Completed
90 enrolled
Gastrointestinal

Agnosia, Colonic Diseases, Colonic Neoplasms, Neoplasms, Pain, Visceral Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡